Fox Jonathan C — SEC insider filings

SEC reporting owner CIK 1655016. 17 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2020-09-16 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Eidos Therapeutics, Inc. (EIDX)See Remarks3—4 legs · 10,000 sh · $501,4823
Edgewise Therapeutics, Inc. (EWTX)Director142 legs · 21,557 sh · $300,361—12

Insider filings — Fox Jonathan C

FiledFormIssuerReported transactionsSource
2026-10-024Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 308 @ $0EDGAR
2026-07-014Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 319 @ $0EDGAR
2026-06-164Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 16,377 (derivative) @ $0EDGAR
2026-04-034Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 339 @ $0EDGAR
2026-01-054Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 473 @ $0EDGAR
2025-11-134Edgewise Therapeutics, Inc. (EWTX)Purchase (P): 10,700 @ $18.64EDGAR
2025-10-024Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 728 @ $0EDGAR
2025-07-024Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 858 @ $0EDGAR
2025-06-184Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-04-034Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 559 @ $0EDGAR
2024-06-124Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 20,594 (derivative) @ $0EDGAR
2023-12-284Edgewise Therapeutics, Inc. (EWTX)Purchase (P): 10,857 @ $9.30EDGAR
2023-06-144Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 22,123 (derivative) @ $0EDGAR
2023-03-074Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 43,731 (derivative) @ $0EDGAR
2021-01-284Eidos Therapeutics, Inc. (EIDX)Gift (G): 500 @ $0 · Code (U): 380,467 · Disposition to issuer (D): 70,000 (derivative)EDGAR
2020-09-184Eidos Therapeutics, Inc. (EIDX)Sale (S): 5,767 @ $50.16EDGAR
2020-09-164Eidos Therapeutics, Inc. (EIDX)Sale (S): 111 @ $50 · Sale (S): 1,000 @ $50.06 · Sale (S): 3,122 @ $50.16EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1655016 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs